Lillian L. Siu

Toronto, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 294 publications

Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.

Metastatic patterns, outcomes, and prognostic factors in de novo metastatic head and neck cancer by tumor HPV status.

Journal: Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology

Published: June 16, 2026

Immune checkpoint blockade sensitivity is linked to endogenous retroelement transcriptional changes in cancer.

Immune checkpoint blockade sensitivity is linked to endogenous retroelement transcriptional changes in cancer.

Journal: Cancer immunology research

Published: May 12, 2026

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Immune profiling by bulk RNA-seq and multiplex immunofluorescence imaging across multiple cancer types.

Journal: Frontiers in oncology

Published: May 09, 2026

Hallmarks of Cancer: How did it inspire you?

Hallmarks of Cancer: How did it inspire you?

Journal: Cell

Published: March 12, 2026

Precision, Partnership, Purpose: Advancing Cancer Science to Save Lives Globally.

Precision, Partnership, Purpose: Advancing Cancer Science to Save Lives Globally.

Journal: Cancer discovery

Published: February 26, 2026

Pan-Cancer Pre-Treatment ctDNA Detection Using a Highly Sensitive Tumor-Informed Assay.

Pan-Cancer Pre-Treatment ctDNA Detection Using a Highly Sensitive Tumor-Informed Assay.

Journal: International journal of molecular sciences

Published: February 14, 2026

JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC.

JADE: phase 3 study of sequential dostarlimab post chemoradiotherapy in patients with locally advanced unresected HNSCC.

Journal: Future oncology (London, England)

Published: January 30, 2026

Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohorts.

Longitudinal validation of ENLIGHT, an AI predictor of immunotherapy response and resistance, in pan-cancer cohorts.

Journal: NPJ precision oncology

Published: January 26, 2026

Advances in cancer immunotherapy: adoptive cell therapy and immune cell engagers in solid tumours.

Advances in cancer immunotherapy: adoptive cell therapy and immune cell engagers in solid tumours.

Journal: British journal of cancer

Published: December 29, 2025

A Phase 1 First-Time-in-Human, Open-Label Study of Nelistotug Administered to Patients with Advanced Solid Tumors.

A Phase 1 First-Time-in-Human, Open-Label Study of Nelistotug Administered to Patients with Advanced Solid Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 27, 2025

CANLead: Canada as a Phase 1 Clinical Trial Leader - Opportunities, Initiatives, and Collaborative Innovation to Elevate National Competitiveness.

CANLead: Canada as a Phase 1 Clinical Trial Leader - Opportunities, Initiatives, and Collaborative Innovation to Elevate National Competitiveness.

Journal: The oncologist

Published: November 24, 2025

Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy.

Methylation-based ctDNA monitoring in metastatic breast cancer during CDK4/6 inhibitor therapy.

Journal: Nature communications

Published: November 18, 2025

Showing 1-12 of 294

Last Updated: 09/26/2026